Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention

Int J Mol Sci. 2019 Nov 26;20(23):5946. doi: 10.3390/ijms20235946.


Nicotinamide (NAM) is an amide form of vitamin B3 and the precursor of nicotinamide adenine dinucleotide (NAD+), an essential co-enzyme of redox reactions for adenosine triphosphate (ATP) production and for other metabolic processes. As NAD+ status is critical in maintaining cellular energy, vitamin B3 deficiency mainly affects tissues that need high cellular energy causing pellagra and skin sun sensitivity. In animal models, NAD+ deficiency leads to UV sensitivity of the skin, impairs DNA damage response, and increases genomic instability and cancer incidence. Furthermore, NAD+ depletion is associated with human skin aging and cancer. NAM prevents the UV-induced ATP depletion boosting cellular energy and enhances DNA repair activity in vitro and in vivo. Moreover, NAM reduces skin cancer incidence and prevents the immune-suppressive effects of UV in mice. Thus, NAM is involved in the maintenance of genomic stability and may have beneficial effects against skin aging changes and tumor development. Clinical studies showed that topical use of NAM reduces cutaneous aging. Furthermore, oral NAM administration reduces the level of UV-mediated immunosuppression and lowers the rate of non-melanoma skin cancers in high-risk patients. Therefore, NAM replenishment strategy may be a promising approach for skin cancer chemoprevention.

Keywords: keratinocytes; nicotinamide; non-melanoma skin cancers; skin aging.

Publication types

  • Review

MeSH terms

  • Animals
  • Energy Metabolism / drug effects
  • Genomic Instability*
  • Humans
  • Immunosuppression Therapy
  • NAD / deficiency
  • Niacinamide / administration & dosage
  • Niacinamide / deficiency*
  • Niacinamide / pharmacology
  • Skin Aging / drug effects*
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / prevention & control
  • Ultraviolet Rays / adverse effects


  • NAD
  • Niacinamide